Supporting oncology professionals through education

The content on this site is intended for healthcare professionals only

News [12724]

Why nanoparticles could prove a game changer for cancer immunotherapy

Why nanoparticles could prove a game changer for cancer immunotherapy

Immunotherapy may be effective for a subgroup of metastatic colorectal cancer patients

Immunotherapy may be effective for a subgroup of metastatic colorectal cancer patients

Statins may improve survival for triple-negative breast cancer patients

Statins may improve survival for triple-negative breast cancer patients

Negative trade-off between neoantigen repertoire breadth and the specificity of HLA-I molecules shapes antitumour immunity

Negative trade-off between neoantigen repertoire breadth and the specificity of HLA-I molecules shapes antitumour...

FDA approves pembrolizumab for high-risk early-stage triple-negative breast cancer

FDA approves pembrolizumab for high-risk early-stage triple-negative breast cancer

Study identifies biomarker for breast cancer response to immunotherapy

Study identifies biomarker for breast cancer response to immunotherapy

Quitting smoking after lung cancer diagnosis may extend life without cancer recurrence

Quitting smoking after lung cancer diagnosis may extend life without cancer recurrence

New breakthrough to help immune systems in the fight against cancer

New breakthrough to help immune systems in the fight against cancer

Phase two CD19-antibody-drug conjugate trial demonstrates promise for aggressive lymphoma

Phase two CD19-antibody-drug conjugate trial demonstrates promise for aggressive lymphoma

Researchers develop novel therapy that could be effective in many cancers

Researchers develop novel therapy that could be effective in many cancers

More from ecancer